Vanda Pharmaceuticals Inc. (VNDA): 11 insider purchases in the last two years (8 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Aug 8, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 10,000 | $4.15 | $41.5K | opportunistic |
| May 21, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 10,000 | $4.40 | $44.0K | opportunistic |
| May 19, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 20,000 | $4.22 | $84.4K | opportunistic |
| Mar 6, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 10,000 | $5.01 | $50.1K | routine |
| Mar 5, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 10,000 | $5.02 | $50.2K | routine |
| Mar 4, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 10,000 | $4.71 | $47.1K | routine |
| Feb 28, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 10,000 | $4.76 | $47.6K | opportunistic |
| Feb 27, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 10,000 | $4.76 | $47.6K | opportunistic |
| Feb 26, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 10,000 | $4.76 | $47.6K | opportunistic |
| Feb 25, 2025 | Polymeropoulos Mihael Hristos Director, Officer, Other | 10,000 | $4.46 | $44.6K | opportunistic |
| Feb 24, 2025 | Moran Kevin Patrick Officer | 2,000 | $4.39 | $8.8K | opportunistic |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.